Big news for anyone struggling with weight loss or diabetes: Novo Nordisk is slashing prices on its blockbuster drugs Wegovy and Ozempic….
Novartis Drops $12 Billion on Biotech Firm — Could This Be the Biggest Medical Breakthrough Yet?
1 Mins read
Novartis Makes a Stunning $12 Billion Move Swiss pharmaceutical giant Novartis has announced it will acquire U.S. biotech company Avidity Biosciences for…
Inside the $5.3 Billion Obesity Drug Deal: Roche and Zealand Pharma's Bold Move to Rival Novo Nordisk and Eli Lilly
3 Mins read
Roche and Zealand Pharma’s $5.3 Billion Gambit: A Game-Changer for Obesity Treatment In a major move in the world of pharmaceuticals, Roche…
Johnson & Johnson to Invest $55 Billion in U.S. Manufacturing as Tariff Concerns Grow
2 Mins read
J&J’s Big Move to Strengthen U.S. Operations In response to potential drug import tariffs by the Trump administration, Johnson & Johnson (J&J)…
AstraZeneca to Invest $2.5 Billion in Beijing Hub, Eyes Future Growth Beyond Chinese Tax Probe
3 Mins read
AstraZeneca’s Major Investment in Beijing In a bold move signaling its long-term commitment to China, British pharmaceutical giant AstraZeneca has announced it…
